CH679246A5 - - Google Patents

Download PDF

Info

Publication number
CH679246A5
CH679246A5 CH95689A CH95689A CH679246A5 CH 679246 A5 CH679246 A5 CH 679246A5 CH 95689 A CH95689 A CH 95689A CH 95689 A CH95689 A CH 95689A CH 679246 A5 CH679246 A5 CH 679246A5
Authority
CH
Switzerland
Prior art keywords
rna
proteolipid
cdna
immunologically equivalent
cells
Prior art date
Application number
CH95689A
Other languages
German (de)
English (en)
Inventor
Kaspar Dr Rhyner
Andreas Dr Wieczorek
Peter Dr Groscurth
Original Assignee
Kaspar Dr Rhyner
Andreas Dr Wieczorek
Peter Dr Groscurth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaspar Dr Rhyner, Andreas Dr Wieczorek, Peter Dr Groscurth filed Critical Kaspar Dr Rhyner
Priority to CH95689A priority Critical patent/CH679246A5/de
Priority to PCT/CH1990/000063 priority patent/WO1990010872A1/de
Priority to AU51726/90A priority patent/AU5172690A/en
Publication of CH679246A5 publication Critical patent/CH679246A5/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH95689A 1989-03-15 1989-03-15 CH679246A5 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH95689A CH679246A5 (ja) 1989-03-15 1989-03-15
PCT/CH1990/000063 WO1990010872A1 (de) 1989-03-15 1990-03-12 Gewinnung und verwendung von rna-proteolipidkomplex aus humanen malignen zellen
AU51726/90A AU5172690A (en) 1989-03-15 1990-03-12 Extraction and use of a rna proteo-lipid complex contained in malignant human cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH95689A CH679246A5 (ja) 1989-03-15 1989-03-15

Publications (1)

Publication Number Publication Date
CH679246A5 true CH679246A5 (ja) 1992-01-15

Family

ID=4199087

Family Applications (1)

Application Number Title Priority Date Filing Date
CH95689A CH679246A5 (ja) 1989-03-15 1989-03-15

Country Status (3)

Country Link
AU (1) AU5172690A (ja)
CH (1) CH679246A5 (ja)
WO (1) WO1990010872A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002249A1 (de) * 1990-08-08 1992-02-20 Viktor Balazs VERFAHREN ZUR VERHINDERUNG DER FUNKTIONSAUSÜBUNG DER GESCHÜTZTEN EXTRAZELLULAREN mRNAs VON KREBSZELLURSPRUNG FÜR PROPHYLAXE BÖSARTIGER KRANKHEITEN BZW. DEREN RELAPSE
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
WO2010079118A1 (en) 2009-01-07 2010-07-15 Michael Roth-Chiarello Use of rna obtained from proteolipid complexes circulating in blood for diagnosis and treatment of tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207170A4 (en) * 1984-12-28 1988-06-23 Taisho Pharmaceutical Co Ltd METHOD FOR PRODUCING HUMAN CANCER-SPECIFIC MONOCLONAL ANTIBODIES.

Also Published As

Publication number Publication date
WO1990010872A1 (de) 1990-09-20
AU5172690A (en) 1990-10-09

Similar Documents

Publication Publication Date Title
DE3687736T2 (de) Monoklonale antikoerper gegen humanen brustkrebs, korrespondierende hybridome, deren herstellung und verwendung.
DE3856108T2 (de) Monoklonale antikörper der zweiten generation mit bindungsspezifität für tag-72 und menschliche karzinome sowie methoden zu ihrer anwendung
DE69432926T2 (de) Humanes carcinoma-antigen (hca), hca antikörper, hca immunoassays, aufzeichnungsmethoden und therapy
DE3883803T2 (de) Monoklonale Antikörper gegen melanoma-assoziierte Antigene, Hybridzellinien, die diese Antikörper produzieren, und ihre Verwendung.
DE3888224T2 (de) Bestimmung vom Tumornekrosefaktor; monoklonaler Antikörper und Zusammensetzung.
DE3751585T3 (de) Hybridome, die monoklonale Antikörper gegen neue Mucin-Epitope produzieren.
DE69306803T2 (de) Kleinzelliger lungenkarzinom-spezifischer antikörper und antigenen
DE3783277T2 (de) Monoklonaler antikoerper gegen humanes lungenkarzinom.
AT400577B (de) Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen
DE2806146A1 (de) Tumor-spezifische gylkoproteine und methode zum nachweis von tumorigenen krebsarten
DE3780480T2 (de) Test fuer menschlichen brustkrebs.
DE3587976T2 (de) Monoklonale antikörper und antigene für menschliche lungenkarzinome vom typ der nichtkleinen zellen.
DE3586216T2 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
DE3218312C2 (de) Monoklonale Antikörper, Hybridoma-Zellklone, Verfahren zu ihrer Herstellung und ihre Verwendung zur Erkennung von Brustkrebs und maligner Lymphogranulomatose
DE60128452T2 (de) Monoklonale antikörper gegen den menschlichen ldl-rezeptor, deren herstellung und verwendung
DE69126038T2 (de) Diagnose von krebs-metastasen durch das mts-1 gen
DE3047654C2 (ja)
EP0955361B1 (de) Monoklonale Antikörper gegen tumorassoziierte Antigene, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE3686438T2 (de) Tumorverbundenes antigen.
DE3688638T2 (de) Monoklonale Antikörper für humane Lungenkarzinome des "Nicht-kleine-Zellen"-Typs.
CH679246A5 (ja)
DE69633976T2 (de) Monoklonale antikörper und antigene mit bezug zum menschlichen lungenadenokarzinom und immunoassay-verfahren unter verwendung desselben
DE3686766T2 (de) Monoklonaler antikoerper gegen glutathion s-transferase und dessen verwendung zur diagnose von krebs.
DE69434024T2 (de) Auf humanen cortikalen thymozyten exprimierte oberflächenproteine und ihre verwendung
DE3785795T2 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.

Legal Events

Date Code Title Description
PL Patent ceased